Female cancer survivors more likely to report cost-related non-adherence
the ONA take:
Significant gender differences in cost-related medication non-adherence (CRN) were found among cancer survivors after adjusting for differences in sociodemographic, health status, and insurance coverage, a new study published online ahead of print in the Journal of Cancer Survivorship.
Because it has been reported that cancer survivors delay or avoid necessary care due to costs, researchers sought to determine the prevalence of CRN by gender and other factors among cancer survivors.
For the study, researchers from the University of South Carolina Arnold School of Public Health, in Columbia, analyzed data from 15,159 cancer survivors. Of those, 7.4% of male and 12.5% of female survivors reported CRN.
Results showed that female cancer survivors were 27% more likely than males to report CRN. Researchers found that a higher number of comorbidities and activity limitations were associated with higher CRN rates for both males and females.
“Given the rapid increase in prescription drug costs, it is important to monitor closely the CRN in high-risk subgroups,” the authors conclude.
Significant gender differences in cost-related medication non-adherence were found among cancer survivors.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|